World Health Organization Grants Second Emergency Use Listing for Novavax COVID-19 Vaccine
– Nuvaxovid™ COVID-19 Vaccine (SARS-CoV-2 rS [Recombinant, adjuvanted]) listed for emergency use by the WHO – EUL for Nuvaxovid complements listing for Novavax vaccine manufactured and marketed by Serum Institute of India as Covovax™ – EUL by WHO is a prerequisite for exports to numerous countries participating in the COVAX Facility Novavax, Inc. (Nasdaq: NVAX), a biotechnology company […]
